Theranostics Market Segmented By Disease's, And By Region- Global Growth, Trends, And Forecast -2023

Theranostics Market Segmented By Disease's, And By Region- Global Growth, Trends, And Forecast -2023

ID: 5971 | Pages: 175 | April 2018 | Region: Global


Market Overview:

Theranostics Market was worth USD XX million in 2018 and estimated to be growing at a CAGR of XX%, to reach USD XX million by 2023. Theranostics is combination of drug therapy and diagnostics.

Theranostics can be termed as a fusion between drug therapeutics and diagnostics to optimize the drug effectiveness, safety and streamline drug development. It is a combination of medical drugs and diagnostics and also referred as pharmacodiagnostics, companion diagnostics and Dx/Rx partnering.

Primary factors accounted for driving the market are increasing financial support for research and development for drug synthesis, to tackle new and fatal diseases, improving co-operation between diagnostic companies and drug manufacturers as well as increasing applications in disease treatment. Conversely, regulatory timelines and expensive prices of theranostic products are the factors hindering the growth of market.

The Global market for Theranostics is segmented based on Disease Type. Based on Disease Type it is divided into Neurological Disorders, Cancers, Cardiovascular Diseases and Others. Based on the geographical analysis, the market is divided into regions of North America, Latin America, Europe, Middle East and Africa and Asia Pacific. North America holds the major share in the market due to presence of market leaders as well as a developed healthcare and pharmaceutical infrastructure. Asia Pacific is the fastest growing region due to increasing expenditure on health care, product innovation and increasing disposable income. Based on Disease Type, Neurological disorders are the holding the major share in the market due to prevalence of diseases like Parkinson’s Disease, Alzheimer’s Disease and other prevalent diseases, meanwhile cancer diseases and cardiovascular disorders are expected to grow the fastest due to increased risk rate and prevalence of these diseases and increasing research expenditure by pharmaceutical companies..

Some of the key players dominating this market include Abbott Laboratories, AmeriPath, Dickinson and Company, BIOTEC Laboratories, Dade Behring, Dianon Systems, Dynacare Laboratories, Enterix, Focus Diagnostics, Pfizer and Beckman Coulter.

1. Introduction                                                 

                1.1 Market Definition                                    

                1.2 Study Deliverables                                  

                1.3 Base Currency, Base Year and Forecast Periods                                          

                1.4 General Study Assumptions                                

2. Research Methodology                                                           

                2.1 Introduction                                               

                2.2 Research Phases                                      

                                2.2.1 Secondary Research                           

                                2.2.2 Primary Research                 

                                2.2.3 Econometric Modelling                      

                                2.2.4 Expert Validation                  

                2.3 Analysis Design                                         

                2.4 Study Timeline                                          

3. Overview                                                       

                3.1 Executive Summary                                

                3.2 Key Inferences                                         

                3.3 Epidemology                                              

4. Drivers, Restraints, Opportunities, and Challenges Analysis (DROC)                                                    

                4.1 Market Drivers                                          

                4.2 Market Restraints                                    

                4.3 Key Challenges                                         

                4.4 Current Opportunities in the Market                                              

5. Market Segmentation                                                              

                5.1 Disease Type                                             

                                5.1.1 Introduction                           

                                5.1.2 Neurological Disorders                       

                                5.1.3 Cardiovascular Diseases                    

                                5.1.4 Cancers                    

                                5.1.5 Others                      

                                5.1.6  Y-o-Y Growth Analysis, By Disease Type                    

                                5.1.7  Market Attractiveness Analysis, By Disease Type                  

                                5.1.8  Market Share Analysis, By Disease Type                   

6. Geographical Analysis                                                              

                6.1 Introduction                                               

                                6.1.1 Regional Trends                    

                                6.1.2 Impact Analysis                     

                                6.1.3 Y-o-Y Growth Analysis                        

                                                6.1.3.1 By Geographical Area     

                                                6.1.3.2 By Disease Type

                                6.1.4  Market Attractiveness Analysis                     

                                                6.1.4.1 By Geographical Area     

                                                6.1.4.2 By Disease Type

                                6.1.5  Market Share Analysis                      

                                                6.1.5.1 By Geographical Area     

                                                6.1.5.2 By Disease Type

                6.2 North America                                          

                                6.1.1 Introduction                           

                                6.1.2 United States                         

                                6.1.3 Canada                     

                6.3 Europe                                         

                                6.2.1 Introduction                           

                                6.2.2 U.K                             

                                6.2.3 Spain                         

                                6.2.4 Germany                 

                                6.2.5 Italy                            

                                6.2.6 France                       

                6.4 Asia-Pacific                                 

                                6.3.1 Introduction                           

                                6.3.2 China                         

                                6.3.3 India                          

                                6.3.4 Japan                         

                                6.3.5 Australia                   

                                6.3.6 South Korea                           

                6.5 Latin America                                             

                                6.4.1 Introduction                           

                                6.4.2 Brazil                          

                                6.4.3 Argentina                

                                6.4.4 Mexico                     

                                6.4.5 Rest of Latin America                          

                6.6 Middle East & Africa                                               

                                6.5.1 Introduction                           

                                6.5.2 Middle-East                            

                                6.5.3 Africa                         

7. Strategic Analysis                                                       

                7.1 PESTLE analysis                                         

                                7.1.1 Political                     

                                7.1.2 Economic                 

                                7.1.3 Social                         

                                7.1.4 Technological                         

                                7.1.5 Legal                          

                                7.1.6 Environmental                       

                7.2 Porter’s Five analysis                                              

                                7.2.1 Bargaining Power of Suppliers                        

                                7.2.2 Bargaining Power of Consumers                    

                                7.2.3 Threat of New Entrants                     

                                7.2.4 Threat of Substitute Products and Services                              

                                7.2.5 Competitive Rivalry within the Industry                     

8. Market Leaders' Analysis                                                        

                8.1 Abbott Laboratories                                               

                                8.1.1 Overview                 

                                8.1.2 Product Analysis                   

                                8.1.3 Financial analysis                  

                                8.1.4 Recent Developments                       

                                8.1.5 SWOT analysis                       

                                8.1.6 Analyst View                          

                8.2 AmeriPath                                  

                8.3 Dickinson and Company                                        

                8.4 BIOTEC Laboratories                                               

                8.5 Dade Behring                                             

                8.6 Dianon Systems                                        

                8.7 Dynacare Laboratories                                           

                8.8 Enterix                                          

                8.9 Focus Diagnostics                                     

                8.10 Pfizer                                          

9. Competitive Landscape                                                           

                9.1 Market share analysis                                            

                9.2 Merger and Acquisition Analysis                                       

                9.3 Agreements, collaborations and Joint Ventures                                         

                9.4 New Product Launches                                         

10. Market Outlook and Investment Opportunities                                                         

Appendix                                                           

                a) List of Tables                                

                b) List of Figures                                              

  • Global and country-level analysis and forecasts of the study market; providing Insights on the major countries/regions in which this industry is blooming and to also identify the regions that are still untapped
  • Segment-level analysis in terms of Region, by Diseases along with market size forecasts and estimations to detect key areas of industry growth in detail
  • Identification of key drivers, restraints, opportunities, and challenges (DROC) in the market and their impact on shifting market dynamics
  • Study of the effect of exogenous and endogenous factors that affect the global market; which includes broadly demographic, economics, and political, among other macro-environmental factors presented in an extensive PESTLE Analysis
  • Study the micro environment factors that determine the overall profitability of an Industry, using Porter’s five forces analysis for analysing the level of competition and business strategy development
  • A comprehensive list of key market players along with their product portfolio, current strategic interests, key financial information, legal issues, SWOT analysis and analyst overview to study and sustain the market environment
  • Competitive landscape analysis listing out the mergers, acquisitions, collaborations in the field along with new product launches, comparative financial studies and recent developments in the market by the major companies
  • An executive summary, abridging the entire report in such a way that decision-making personnel can rapidly become acquainted with background information, concise analysis and main conclusions
  • Expertly devised analyst overview along with Investment opportunities to provide both individuals and organizations a strong financial foothold in the market

                                                                                                                          

TitlePriceAdd To Cart
  1. Global Theranostics Market By Region, From 2018–2023 ( USD Million )
  2. Global Theranostics Market By Disease Type, From 2018–2023 ( USD Million )
  3. Global Neurological Disorders Market By Region, From 2018–2023 ( USD Million )
  4. Global Cardivascular Disorders Market By Region, From 2018–2023 ( USD Million )
  5. Global Cancers Market By Region, From 2018–2023 ( USD Million )
  6. Global Others Market By Region, From 2018–2023 ( USD Million )
  7. North America Theranostics Market By Disease Type, From 2018–2023 ( USD Million )
  8. North America Neurological Disorders Market By Region, From 2018–2023 ( USD Million )
  9. North America Cardivascular Disorders Market By Region, From 2018–2023 ( USD Million )
  10. North America Cancers Market By Region, From 2018–2023 ( USD Million )
  11. North America Others Market By Region, From 2018–2023 ( USD Million )
  12. United States Theranostics Market By Disease Type, From 2018–2023 ( USD Million )
  13. Canada Theranostics Market By Disease Type, From 2018–2023 ( USD Million )
  14. Europe Theranostics Market By Disease Type, From 2018–2023 ( USD Million )
  15. Europe Neurological Disorders Market By Region, From 2018–2023 ( USD Million )
  16. Europe Cardivascular Disorders Market By Region, From 2018–2023 ( USD Million )
  17. Europe Cancers Market By Region, From 2018–2023 ( USD Million )
  18. Europe Others Market By Region, From 2018–2023 ( USD Million )
  19. U.K. Theranostics Market By Disease Type, From 2018–2023 ( USD Million )
  20. Germany Theranostics Market By Disease Type, From 2018–2023 ( USD Million )
  21. France Theranostics Market By Disease Type, From 2018–2023 ( USD Million )
  22. Italy Theranostics Market By Disease Type, From 2018–2023 ( USD Million )
  23. Spain Theranostics Market By Disease Type, From 2018–2023 ( USD Million )
  24. Asia Pacific Theranostics Market By Disease Type, From 2018–2023 ( USD Million )
  25. Asia Pacific Neurological Disorders Market By Region, From 2018–2023 ( USD Million )
  26. Asia Pacific Cardivascular Disorders Market By Region, From 2018–2023 ( USD Million )
  27. Asia Pacific Cancers Market By Region, From 2018–2023 ( USD Million )
  28. Asia Pacific Others Market By Region, From 2018–2023 ( USD Million )
  29. Japan Theranostics Market By Disease Type, From 2018–2023 ( USD Million )
  30. China Theranostics Market By Disease Type, From 2018–2023 ( USD Million )
  31. India Theranostics Market By Disease Type, From 2018–2023 ( USD Million )
  32. Australia Theranostics Market By Disease Type, From 2018–2023 ( USD Million )
  33. South Korea Theranostics Market By Disease Type, From 2018–2023 ( USD Million )
  34. Latin America Theranostics Market By Disease Type, From 2018–2023 ( USD Million )
  35. Latin America Neurological Disorders Market By Region, From 2018–2023 ( USD Million )
  36. Latin America Cardivascular Disorders Market By Region, From 2018–2023 ( USD Million )
  37. Latin America Cancers Market By Region, From 2018–2023 ( USD Million )
  38. Latin America Others Market By Region, From 2018–2023 ( USD Million )
  39. Brazil Theranostics Market By Disease Type, From 2018–2023 ( USD Million )
  40. Argentina Theranostics Market By Disease Type, From 2018–2023 ( USD Million )
  41. Mexico Theranostics Market By Disease Type, From 2018–2023 ( USD Million )
  42. Rest of Latin America Theranostics Market By Disease Type, From 2018–2023 ( USD Million )
  43. Middle East and Africa Theranostics Market By Disease Type, From 2018–2023 ( USD Million )
  44. Middle East and Africa Neurological Disorders Market By Region, From 2018–2023 ( USD Million )
  45. Middle East and Africa Cardivascular Disorders Market By Region, From 2018–2023 ( USD Million )
  46. Middle East and Africa Cancers Market By Region, From 2018–2023 ( USD Million )
  47. Middle East and Africa Others Market By Region, From 2018–2023 ( USD Million )
  48. Middle East Theranostics Market By Disease Type, From 2018–2023 ( USD Million )
  49. Africa Theranostics Market By Disease Type, From 2018–2023 ( USD Million )
Middle-East & Africa Cardiovascular Therapeutic Drugs By Disease (Arteriosclerosis, Cardiac Arrhythmias, Myocardial Infarction, Acute Coronary Syndrome, Peripheral Artery Disease, Coronary Artery Disease, Hypertensi...
Middle East And Africa Clostridium Botulinum Market By Product ( Botulinum Toxin Type A And Botulinum Toxin Type B), By End User ( Aesthetic And Therapeutics), By Distribution Channel ( Hospitals, Clinics And Retail...
Latin America Clostridium Botulinum Market By Product ( Botulinum Toxin Type A And Botulinum Toxin Type B), By End User ( Aesthetic And Therapeutics), By Distribution Channel ( Hospitals, Clinics And Retail Pharmaci...
Asia Pacific Clostridium Botulinum Market By Product (botulinum Toxin Type A And Botulinum Toxin Type B), By End User (aesthetic And Therapeutics), By Distribution Channel (hospitals, Clinics And Retail Pharmacies) ...
Europe Clostridium Botulinum Market By Product ( Botulinum Toxin Type A And Botulinum Toxin Type B), By End User ( Aesthetic And Therapeutics), By Distribution Channel ( Hospitals, Clinics And Retail Pharmacies) And...
North America Clostridium Botulinum Market By Product ( Botulinum Toxin Type A And Botulinum Toxin Type B), By End User ( Aesthetic And Therapeutics), By Distribution Channel ( Hospitals, Clinics And Retail Pharmaci...
Clostridium Botulinum Market By Product ( Botulinum Toxin Type A And Botulinum Toxin Type B), By End User ( Aesthetic And Therapeutics), By Distribution Channel ( Hospitals, Clinics And Retail Pharmacies) And By Reg...
The Dental Bone Graft Substitutes Market Is Predicted To Reach USD 664.3 Million With A CAGR Of 9.8% According To Market Data Forecast Report....
Middle East And Africa Dental Bone Graft Substitutes Market By Type ( Synthetic Bone Graft, Xenograft, Allograft And Demineralised Allograft) , By Application ( Socket Preservation, Ridge Augmentation, Periodontal D...
Latin America Dental Bone Graft Substitutes Market By Type ( Synthetic Bone Graft, Xenograft, Allograft And Demineralised Allograft) , By Application ( Socket Preservation, Ridge Augmentation, Periodontal Defect Reg...
Asia-Pacific Dental Bone Graft Substitutes Market By Type ( Synthetic Bone Graft, Xenograft, Allograft And Demineralised Allograft) , By Application ( Socket Preservation, Ridge Augmentation, Periodontal Defect Rege...
Europe Dental Bone Graft Substitutes Market By Type ( Synthetic Bone Graft, Xenograft, Allograft And Demineralised Allograft) , By Application ( Socket Preservation, Ridge Augmentation, Periodontal Defect Regenerati...

"We Think Through Different Layers, We Work Across Different Verticals."

Market Data Forecast, Inc.
2nd Floor, Lakeview Plaza, Kavuri Hills, Hyderabad, Telangana 500033, India.
+1-888-702-9626 (U.S. TOLL FREE)
contact@marketdataforecast.com


Subscribe To Our News Letter

Or follow us on social platform

© 2018 Market Data Forecast
All Rights Reserved.